EFFIENT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Effient, and what generic alternatives are available?
Effient is a drug marketed by Cosette and is included in one NDA.
The generic ingredient in EFFIENT is prasugrel hydrochloride. There are nineteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the prasugrel hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Effient
A generic version of EFFIENT was approved as prasugrel hydrochloride by UNICHEM on August 28th, 2023.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for EFFIENT?
- What are the global sales for EFFIENT?
- What is Average Wholesale Price for EFFIENT?
Summary for EFFIENT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 129 |
Clinical Trials: | 51 |
Patent Applications: | 1,363 |
Drug Prices: | Drug price information for EFFIENT |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for EFFIENT |
What excipients (inactive ingredients) are in EFFIENT? | EFFIENT excipients list |
DailyMed Link: | EFFIENT at DailyMed |
Recent Clinical Trials for EFFIENT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Severance Hospital | Phase 4 |
Ewha Woman's University Seoul Hospital | Phase 4 |
International St. Mary's Hospital | Phase 4 |
Pharmacology for EFFIENT
Drug Class | P2Y12 Platelet Inhibitor |
Mechanism of Action | P2Y12 Receptor Antagonists |
Physiological Effect | Decreased Platelet Aggregation |
Paragraph IV (Patent) Challenges for EFFIENT
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
EFFIENT | Tablets | prasugrel hydrochloride | 5 mg and 10 mg | 022307 | 17 | 2013-07-10 |
US Patents and Regulatory Information for EFFIENT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cosette | EFFIENT | prasugrel hydrochloride | TABLET;ORAL | 022307-001 | Jul 10, 2009 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Cosette | EFFIENT | prasugrel hydrochloride | TABLET;ORAL | 022307-002 | Jul 10, 2009 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for EFFIENT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cosette | EFFIENT | prasugrel hydrochloride | TABLET;ORAL | 022307-001 | Jul 10, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Cosette | EFFIENT | prasugrel hydrochloride | TABLET;ORAL | 022307-001 | Jul 10, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Cosette | EFFIENT | prasugrel hydrochloride | TABLET;ORAL | 022307-002 | Jul 10, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Cosette | EFFIENT | prasugrel hydrochloride | TABLET;ORAL | 022307-002 | Jul 10, 2009 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for EFFIENT
See the table below for patents covering EFFIENT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Korea | 20030065558 | ⤷ Sign Up | |
Czech Republic | 287181 | Tetrahydrothienopyridinové deriváty, jejich furo a pyrroloanalogy a jejich příprava a použití pro inhibici agregace krevních destiček (Tetrahydrothienopyridine derivatives, their furo and pyrrolo analogs, process of their preparation and pharmaceutical preparation) | ⤷ Sign Up |
Hungary | 0301645 | ⤷ Sign Up | |
New Zealand | 526540 | Medicinal compositions containing aspirin and 2-acetoxy-5-(alpha-cyclopropylcarbonyl-2-flurobenzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine useful in preventing thrombus or embolus diseases | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for EFFIENT
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0542411 | SPC/GB09/032 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: PRASUGREL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK EU/1/08/503/001 20090225; UK EU/1/08/503/002 20090225; UK EU/1/08/503/003 20090225; UK EU/1/08/503/004 20090225 |
0542411 | C300397 | Netherlands | ⤷ Sign Up | PRODUCT NAME: PRASUGREL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/08/503/001-014 20090225 |
0542411 | 91589 | Luxembourg | ⤷ Sign Up | 91589, EXPIRES: 20170909 |
0542411 | 300397 | Netherlands | ⤷ Sign Up | 300397, 20120909, EXPIRES: 20170908 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |